Mullica Hill, NJNCT07587658Now EnrollingIRB Ready

Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial in Mullica Hill, NJ

Access cutting-edge chronic obstructive pulmonary disease (copd) treatment through this phase 4 clinical trial at a research site in Mullica Hill. Study-provided care at no cost to qualified participants.

Sponsored by Regeneron Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Mullica Hill location

Preparing your pre-screening questions…

Expert Care in Mullica Hill

Access chronic obstructive pulmonary disease (copd) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic obstructive pulmonary disease (copd) treatment provided free

Apply for This Mullica Hill Location

Check if you qualify for this chronic obstructive pulmonary disease (copd) clinical trial in Mullica Hill, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Mullica Hill

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Mullica Hill site if eligible
  4. 4Begin participation

About This Chronic Obstructive Pulmonary Disease (COPD) Study in Mullica Hill

This study is researching a drug called dupilumab, referred to as "study drug". The study is focused on people diagnosed with COPD to determine if the study drug, in addition to standard of care treatment for COPD, might reduce the reoccurrence of a COPD exacerbation (a "flare-up") happening within the study treatment duration (around 90 days). The study is looking at another research question: • What side effects may happen from taking the study drug

Sponsor: Regeneron Pharmaceuticals

Who Can Participate

Inclusion Criteria

Has a clinical diagnosis of COPD prior to randomization, as defined in the protocol
Hospitalized or admitted to the ED \>24 hours (from time of first admission or presentation to the ED) for acute exacerbation of COPD as primary diagnosis according to the principal investigator and exacerbation is managed by Systemic Corticosteroids (SCS) ± antibiotics and other appropriate treatments as per SOC
Elevated blood eosinophil counts during the current exacerbation, as defined in the protocol. The exacerbation event starts from the day Systemic Corticosteroids (SCS) ± antibiotics are administered continuously up to the day they presented to ED/hospital Key

Exclusion Criteria

Clinical evidence of pneumonia as the primary cause of admission in the investigator's opinion or acquired during hospital stay
Complicating pulmonary conditions during the 8 weeks prior to randomization which may confound treatment assessments, as defined in the protocol
Clinically significant pulmonary diseases other than COPD which may impair lung function and interfere with treatment assessments
Participants with clinically significant α-1 anti-trypsin deficiency which may impair lung function and interfere with treatment assessments
Cardiac-related comorbidity, as defined in the protocol
Treatment with invasive mechanical ventilation in-hospital during the index event, as defined in the protocol
Any biologic therapy or biologic Investigational Medicinal Product (IMP) to treat type 2 inflammatory diseases within 6 months prior to the screening visit or 5 half-lives, whichever is longer, as defined in the protocol NOTE: Other Protocol-defined Inclusion/Exclusion Criteria Apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Mullica Hill?

Yes, this clinical trial (NCT07587658) has an active research site in Mullica Hill, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Obstructive Pulmonary Disease (COPD) Treatment Options in Mullica Hill, NJ

If you're searching for chronic obstructive pulmonary disease (copd) treatment options in Mullica Hill, NJ, this clinical trial (NCT07587658) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Mullica Hill research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced chronic obstructive pulmonary disease (copd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic obstructive pulmonary disease (copd) clinical trials near you to find additional studies recruiting in your area.

More Parkinsons Disease Trials in Mullica Hill, NJ

See all parkinsons disease clinical trials recruiting in Mullica Hill — not just this study.

Browse Parkinsons Disease Trials in Mullica Hill →

Browse More Trials by Condition

Parkinsons Disease TrialsUlcerative Colitis TrialsAnkylosing Spondylitis TrialsCOPD TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Mullica Hill?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Mullica Hill, NJ